NCI Definition: A benign or malignant, primary or metastatic neoplasm that affects the brain, meninges, or spinal cord. Representative examples of primary neoplasms include astrocytoma, oligodendroglioma, ependymoma, and meningioma. Representative examples of metastatic neoplasms include carcinoma and leukemia. [1]

Central nervous system neoplasms most frequently harbor alterations in TP53, IDH1, CDKN2A, CDKN2B, and PTEN [2].

Most Commonly Altered Genes in Central Nervous System Neoplasm

TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, IDH1 Mutation, and IDH1 Codon 132 Missense are the most common alterations in central nervous system neoplasm [2].

Top Alterations in Central Nervous System Neoplasm

Significant Genes in Central Nervous System Neoplasm





Disease Details

Tumor of the CNS, Neoplasm of Central Nervous System, Central Nervous System Tumor, CNS Tumor, Tumor of the Central Nervous System, Tumor of CNS, Tumor of Central Nervous System, Neoplasm of the Central Nervous System, Neoplasm of CNS, CNS Neoplasm
Solid Neoplasm
Oligodendroglial Tumor, Central Nervous System Mesenchymal Non-meningothelial Tumor, Central Nervous System Hemangioblastoma, Neuronal and Mixed Neuronal-Glial Tumors, Central Nervous System Melanocytic Neoplasm, Benign Central Nervous System Neoplasm, Intraspinal Meningioma, Meningeal Neoplasm, Ependymal Tumor, Cauda Equina Neoplasm, Intracranial Neoplasm, Malignant Central Nervous System Neoplasm, Astrocytic Tumor, Central Nervous System Germ Cell Tumor, Spinal Cord Neoplasm, Epidural Spinal Canal Neoplasm, Mixed Glioma, and Intradural Extramedullary Spinal Canal Neoplasm
OncoTree Name
OncoTree Code


1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.